These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 3029830

  • 1. [False-positive findings of 67-gallium scintigraphy in staging/restaging of malignant lymphoma].
    Bihl H, Kimmig B.
    Rofo; 1987 Feb; 146(2):172-7. PubMed ID: 3029830
    [Abstract] [Full Text] [Related]

  • 2. [Role of radiogallium in the staging and follow-up of lymphomas].
    Palumbo R.
    Radiol Med; 1980 Oct; 66(10):746-8. PubMed ID: 6939031
    [No Abstract] [Full Text] [Related]

  • 3. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE, Nagel JS, Tumeh SS.
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [Abstract] [Full Text] [Related]

  • 4. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD, Eller D, Ashook G, Ramanna L, Brachman M, Heifetz L, McAndrews P, Bierman H, Taub R, Avedo M, Wall F.
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C, Reman O, Henry-Amar M, Peny AM, Macro M, Cheze S, Génot JY, Tanguy A, Switsers O, Van HL, Couëtte JE, Leporrier M, Bardet S.
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of FDG-PET in malignant lymphoma.
    Becherer A, Jaeger U, Szabo M, Kletter K.
    Q J Nucl Med; 2003 Mar; 47(1):14-21. PubMed ID: 12714950
    [Abstract] [Full Text] [Related]

  • 7. Gallium-67-citrate scanning for the localization and staging of lymphomas.
    Adler S, Parthasarathy KL, Bakshi SP, Stutzman L.
    J Nucl Med; 1975 Apr; 16(4):255-60. PubMed ID: 1089769
    [Abstract] [Full Text] [Related]

  • 8. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
    Mouratidis B, Gilday DL, Ash JM.
    Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
    [Abstract] [Full Text] [Related]

  • 9. Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomas.
    Turner DA, Fordham EW, Ali A, Slayton RE.
    Semin Nucl Med; 1978 Jul; 8(3):205-18. PubMed ID: 715464
    [Abstract] [Full Text] [Related]

  • 10. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
    Larcos G, Farlow DC, Antico VF, Gruenewald SM, Boyages J.
    Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
    [Abstract] [Full Text] [Related]

  • 11. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
    Setoain FJ, Pons F, Herranz R, Vidal-Sicart S, Lomeña F, Ayuso C, Montserrat E, Setoain J.
    Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
    [Abstract] [Full Text] [Related]

  • 12. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC, Sun SS, Lin CC, Kao CH, Lee CC.
    Anticancer Res; 2001 May; 21(5):3695-8. PubMed ID: 11848545
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
    Bendini M, Zuiani C, Bazzocchi M, Dalpiaz G, Zaja F, Englaro E.
    MAGMA; 1996 May; 4(3-4):213-24. PubMed ID: 9220410
    [Abstract] [Full Text] [Related]

  • 14. Gallium-67 and technetium-99m-MDP scintigraphy for osseous involvement in lymphoma.
    Van de Wiele C, Dierckx RA, Simons M, Noens L.
    J Nucl Med; 1996 Mar; 37(3):548. PubMed ID: 8772667
    [No Abstract] [Full Text] [Related]

  • 15. [Gallium-67 imaging in the diagnosis of malignant lymphoma].
    Kubo A, Nakayama T, Shigematsu N, Kondoh M, Hashimoto S.
    Rinsho Hoshasen; 1985 Oct; 30(11):1301-9. PubMed ID: 3910873
    [No Abstract] [Full Text] [Related]

  • 16. [SPECT-CT 67Ga studies in lymphoma disease. Contribution to staging and follow-up].
    Fuertes Manuel J, Estorch Cabrera M, Camacho Martí V, Flotats Giralt A, Rodríguez-Revuelto AA, Hernández Fructuoso MA, Carrió Gasset I.
    Rev Esp Med Nucl; 2006 Oct; 25(4):242-9. PubMed ID: 16827987
    [Abstract] [Full Text] [Related]

  • 17. [Clinical usefulness of 67Ga-citrate scintigraphy combined early image in malignant lymphoma--detection of abdominal lesions].
    Okazaki A, Katoh S, Noda M, Katsumata Y, Shirouzu I, Maehara T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug 25; 50(8):1007-15. PubMed ID: 2235335
    [Abstract] [Full Text] [Related]

  • 18. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O, Mekel M, Bar-Shalom R, Epelbaum R, Hermony N, Haim N, Dann EJ, Frenkel A, Ben-Arush M, Gaitini D.
    J Nucl Med; 2002 Oct 25; 43(10):1295-303. PubMed ID: 12368366
    [Abstract] [Full Text] [Related]

  • 19. [Clinical staging and diagnosis of malignant lymphoma].
    Niibe H, Tamaki Y, Akimoto T.
    Gan No Rinsho; 1988 Apr 25; 34(5):541-54. PubMed ID: 3164415
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic value of gallium-67 in malignant lymphoma.
    Makoski HB, Teske HJ, Becker G.
    Acta Radiol Ther Phys Biol; 1976 Aug 25; 15(4):321-8. PubMed ID: 983781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.